Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Organ-on-Chip System Offers Insights Into Tumor Interactions and Treatment Response

By LabMedica International staff writers
Posted on 16 Nov 2026

Solid tumors interact closely with blood vessels, nerves, and surrounding tissues, making it difficult to study tumor growth, invasion, pain, and treatment response under controlled laboratory conditions. More...

Organ-on-chip technology offers a way to recreate key aspects of these complex interactions outside the body. Using this approach, researchers have developed a human organ-on-chip model to investigate how cancer interacts with its surrounding microenvironment.

Researchers at Linköping University (LiU; Linköping, Sweden), in collaboration with Politecnico di Milano in Italy, developed a human organ-on-chip model of head and neck cancer. The system consists of a transparent, postage stamp-sized platform that allows cancer cells to grow alongside nerve cells and blood vessel-like structures. By recreating key features of the tumor microenvironment, the model enables researchers to study cancer interactions with surrounding tissues and evaluate drug responses under controlled laboratory conditions.

The model was developed in three stages to recreate key components of the tumor microenvironment. Researchers first created a material mimicking the extracellular matrix using hyaluronic acid, collagen, and laminins. They found that its composition significantly influenced cancer cell behavior and response to chemotherapy. Next, they introduced blood vessel-like structures and observed cancer cells rapidly migrating toward and invading them, with the extent of invasion varying according to the surrounding matrix.

The researchers also used the vessel-like structures to deliver cisplatin, a chemotherapy drug commonly used to treat head and neck cancer. The effectiveness of the treatment depended on the composition of the extracellular matrix. Finally, they used stem cells to recreate trigeminal ganglia, which give rise to nerves involved in facial and oral sensation and pain. Within days, nerve fibers had grown around the tumors, further replicating the complex interactions within the tumor microenvironment.

The study was published online on October 27, 2026, in Proceedings of the National Academy of Sciences (PNAS). The researchers stated that the organ-on-chip model could be adapted to other solid tumor types in which interactions with surrounding tissues are important. They also noted that the method could support studies of cancer behavior and may eventually be useful for drug screening and testing treatment response.

“In our three-dimensional system, we saw that tumours in contact with nerves were less likely to invade blood vessels, but at the same time grew larger. Our model enables us to study nerves as an active component of the tumour microenvironment. This is particularly interesting in head and neck cancer, where nerves are involved both in regulating tumour behaviour and aggressiveness, and in cancer-related pain,” said Pierfrancesco Pagella, Senior Associate Professor at Linköping University, who led the study published in PNAS.

Related Links
Linköping University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.